Consensus TaiMed Biologics Inc.

Equities

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
88 ^TWD	+0.92%		+1.73%	+7.32%

May. 10	TaiMed Biologics Inc. Announces Enrollment of the Last Patient in Phase 2a Study of the Long-Acting TMB-365/TMB-380 Mabcombination for the Bi-Monthly Maintenance HIV Therapy	CI
Mar. 20	TaiMed Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

b29dd712f6.qYil3lFBOSDp3cSdlkJSFN9xsrvXdt0T8lh66ZJnt2k.-ubQtyQ3WEmCiJ718w8DJpEZ98qdEo9Mvz4WoME38C7t0uewHghzTJyoqw~cbdd45ae9245d0eb14768e8ea704400c

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

88 TWD

Average target price

133.7 TWD

Spread / Average Target

+51.92%

High Price Target

173 TWD

Spread / Highest target

+96.59%

Low Price Target

108.1 TWD

Spread / Lowest Target

+22.80%

Trading Rating

Investor Rating

ESG Refinitiv

C-